NEW YORK, May 30, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Inari Medical, Inc. ("Inari Medical" or the "Company") (NASDAQ: NARI) of a class action securities lawsuit. NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate. WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholde ...

NEW YORK, May 29, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Inari Medical, Inc. (NASDAQ: NARI). Shareholders who purchased shares of NARI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/inari-medical-inc-loss-submission-form/?id=81712&from=4 DEADLINE: July 12, 2024 Sha ...

NEW YORK, May 28, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inari Medical, Inc. (NASDAQ: NARI) between February 24, 2022 and February 28, 2024, both dates inclusive (the "Class Period"), of the important July 12, 2024 lead plaintiff deadline. SO WHAT: If you purchased Inari Medical common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrang ...

Inari Medical, Inc. (NARI) recently announced that it has filed a patent infringement lawsuit against Imperative Care and its subsidiary, Truvic Medical. Inari Medical filed the lawsuit in the U.S. District Court for the Northern District of California. The company seeks injunctive relief and damages for infringement. Inari Medical believes that Truvic is violating eight of its patents related to the treatment of deep vein thrombosis (DVT) and pulmonary emboli using aspiration-based thrombectomy devices. Tr ...

RADNOR, Pa., May 26, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Inari Medical, Inc. ("Inari Medical") (NASDAQ: NARI) on behalf of investors who purchased or acquired Inari Medical common stock between February 24, 2022 through February 28, 2024, inclusive (the "Class Period"). The action charges Inari Medical wit ...

BENSALEM, Pa., May 24, 2024 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Inari Medical, Inc. ("Inari" or the "Company") (NASDAQ: NARI). Class Period: February 24, 2022 – February 28, 2024 Lead Plaintiff Deadline: July 12, 2024 This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Contacts Law Offices of Howard G. S ...

Inari Medical, Inc. (NARI) is well-poised for growth, backed by a huge market opportunity for its products and its commitment to understanding the venous system. However, its dependency on the adoption of products is concerning. Shares of this Zacks Rank #3 (Hold) company have lost 26.5% year to date against the industry's 9% growth. The S&P 500 Index has risen 12.1% in the same time frame. NARI, with a market capitalization of $2.66 billion, is a commercial-stage medical device company. It seeks to develop ...

IRVINE, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) ("Inari"), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today that it had filed a patent infringement lawsuit against Imperative Care, Inc. and Truvic Medical, Inc. (collectively, "Truvic"). The suit was filed in the United States District Court for the Northern District of California. Inari is seeking injunctive relief and damages fo ...

NEW YORK, May 22, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Inari Medical, Inc. ("Inari" or the "Company") (NASDAQ: NARI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. The class action concerns whether Inari and certain of its officers and ...

WHAT TO DO NEXT: To join the Inari Medical class action, go to https://rosenlegal.com/submit-form/? case_id=22855 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 12, 2024. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. WHY ROSEN LAW: We encourage in ...